Personalizing class I anti-arrhythmic drug therapy

Ended Project Grant Awarded Last action

Award ID
R01HL148803
Recipient
Awarding agency
Obligated
$4,347,162

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $4,280,111.60 Federal
  • $67,050.00 Non-federal
Place of performance
University City, MO 63130, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$953 $0
Amendment $45,773 $0
Amendment $514,935 $0
Amendment $514,935 $0
Amendment $572,150 $0
Amendment $572,150 $0
Amendment $572,150 $0
Amendment $67,050 $0
Amendment $67,050 $67,050
Amendment $67,050 $0
Amendment $603,441 $0
Amendment $0 $0
Original award $684,381 $0
Show all 13

Subawards

Subrecipient Amount Awarded
Institut National De La Sante Et De La Recherche Medicale Scope of work for the first year: The overall purpose of the project is to identify the native phosphorylation sites of the cardiac Nav1.5 channels in the… $0
Institut National De La Sante Et De La Recherche Medicale $0
Subrecipient not on record $88,506
Subrecipient not on record $98,431
Subrecipient not on record $98,431

Quick answers

Who received award R01HL148803?

R01HL148803 was awarded to The Washington University by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2020.

How much is award R01HL148803 worth?

$4,347,162 has been obligated on R01HL148803: $4,280,112 in federal funding and $67,050 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award